Haleon Plc in Consumer Health

March 2023

After a successful demerger from GlaxoSmithKline Pc, Haleon Plc, formed in July 2022, continues to lead the consumer health industry, supported by its power brands. While North America is a key region, Asia Pacific, and the Middle East and Africa have provided significant gains.. As Rx-to-OTC switches dry up, Haleon will continue to look for strategic investments to grow inorganically. There are opportunities to expand in preventative health outside its Caltrate and Centrum brands.

USD 570
Request More Information

Delivery: 

Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).

This report comes in PPT.

Overview:

Euromonitor International's report on Haleon plc delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Haleon plc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Haleon plc.

This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWPT analysis of Haleon plc provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research you can trust:

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Download Table of Contents
Scope
Executive summary
Haleon Plc is the market leader in consumer health
Haleon’s global footprint
Company overview
US will lead more than half of future growth
Haleon leads, with Nestlé SA making some significant strides
Fastest growing companies cluster in Asia and show strength in prevention categories
Market leading positions in main markets propel Haleon’s global lead
Top brand Centrum still has potential to increase sales in leading markets
Investment in Panadol results in strong growth in Middle East and Africa
Voltaren maintains number one position in analgesics globally, thanks to growth in the US
Balanced portfolio within vitamins and dietary supplements supports overall growth
Strategic acquisitions in markets other than Asia Pacific and North America are necessary
Caltrate dominates Haleon’s dietary supplements sales
China and the US will continue to be key growth markets over the forecast period
Opportunity analysis: dietary supplements in Western Europe
Through probiotic supplements, Haleon can offer holistic digestive health
North America and Europe are the largest markets for Haleon in CCAs
Decongestants and combination products dominate Haleon’s CCA portfolio
Losses by Nexium cancel out gains by Tums in North America
Dermatological portfolio might benefit from further divestures
A natural sleep aid brand with a wellness proposition can help Haleon make inroads
Key findings
Projected company sales: FAQs (1)
Projected company sales: FAQs (2)

Consumer Health

It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing

See All of Our Definitions
Share:

Why buy this report:

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!

© 2024 Euromonitor is privately owned & trademarked. VAT No. GB: 239-2559-40 Registered in England No. 1040587
;